B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

YAP1

MOLECULAR TARGET

Yes1 associated transcriptional regulator

UniProt: P46937NCBI Gene: 1041341 compounds

YAP1 (Yes1 associated transcriptional regulator) is targeted by 41 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting YAP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Colchicine1.614
2Resveratrol1.393
3Daunorubicin1.393
4Rotenone1.393
5Pueraria1.102
6Azacitidine1.102
7Azacitidine1.102
8Camptothecin1.102
9cycloheximide1.102
10Dactinomycin1.102
11deguelin [Supplementary Concept]1.102
12Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is1.102
13Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of1.102
14Ouabain1.102
15Podophyllotoxin1.102
16Thapsigargin1.102
17Berberine0.691
18Genistein0.691
192-Methoxyestradiol0.691
20Anisomycin0.691
21Antimycin0.691
22Azauridine0.691
23Benzalkonium Compounds0.691
24celastrol0.691
25Cetylpyridinium Cationic bactericidal surfactant used as0.691
26Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.0.691
27dihydrorotenone0.691
28Emetine0.691
29Gliotoxin0.691
30Homoharringtonine Semisynthetic derivative of harringtonine that acts as0.691
31Monensin0.691
32Monocrotaline0.691
33Nigericin0.691
34Nocodazole Nocodazole is0.691
35Plicamycin0.691
36Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide.0.691
37Tilorone0.691
38Tripterygium0.691
39Tubercidin0.691
40tyrphostin 90.691
41Valinomycin0.691

About YAP1 as a Drug Target

YAP1 (Yes1 associated transcriptional regulator) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 41 compounds with documented YAP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

YAP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.